Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Hypertension US FDA label
Kidney dosing: Amlodipine (single-agent)Show full dosing details
- eGFR ≥60
- Usual dosing: 5 mg once daily, maximum 10 mg (label).
- eGFR 30–59
- No adjustment (label).
- eGFR 15–29
- No adjustment (label).
- eGFR <15 (not on dialysis)
- Usual initial dose (label: patients with renal failure).
- Hemodialysis (intermittent)
- No adjustment; hemodialysis is unlikely to remove amlodipine (label, Overdosage).
- Peritoneal dialysis
- No label adjustment; no PD data (amlodipine is hepatically cleared and not dialyzed).
- CRRT
- No data in label.
- Dialyzable? No: highly protein bound; hemodialysis not likely to help (label).
- Monitoring Blood pressure, edema. Lower starting dose (2.5 mg) in older adults and hepatic impairment (label).
From the Amlodipine monograph (renalcarematters.com, reviewed).
Use: As an adjunct to diet for the treatment of adults with: ∘ Primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia. US FDA label
Use: Hypertension , to lower blood pressure in adults and children 1 year and older. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 5 mg/160 mg/10 mg, 5 mg/160 mg/5 mg, 5 mg/80 mg/10 mg, 5 mg/80 mg/5 mg
Registered products in the Philippines
4 products registered with the Food and Drug Administration (FDA) Philippines list Amlodipine + Rosuvastatin + Valsartan as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products4
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Exone-RAmlodipine (as besilate) + Valsartan + Rosuvastatin (as calcium) | 5 mg/160 mg/10 mg Film Coated TabletAlu-Alu Blister Pack of 10's. (Box of 30's) | Rx | HK Inno.N CorporationKorea | Medinova Pharmaceutical Inc. | DR-XY49224 | Sep 24, 2029 | |
Exone-RAmlodipine (as besilate) + Valsartan + Rosuvastatin (as calcium) | 5 mg/160 mg/5 mg Film Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's) | Rx | HK Inno. N CorporationKorea | Medinova Pharmaceutical Inc. | DR-XY49225 | Sep 24, 2029 | |
Exone-RAmlodipine (as besilate) + Valsartan + Rosuvastatin (as calcium) | 5 mg/80 mg/10 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | HK Inno.N CorporationKorea | Medinova Pharmaceutical Inc. | DR-XY49226 | Sep 24, 2029 | |
Exone-RAmlodipine (as besilate) + Valsartan + Rosuvastatin (as calcium) | 5 mg/80 mg/5 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | HK Inno.N CorporationKorea | Medinova Pharmaceutical Inc. | DR-XY49227 | Sep 24, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
